Targeting eIF4GI translation initiation factor affords an attractive therapeutic strategy in multiple myeloma

Our findings substantiate that translation initiation of particular targets in MM is contingent on the function of eIF4GI, critical to cell phenotype, and mark it as a viable target for pharmacological intervention.